Subscribe To
Archer-daniels-midland: watching the grass grow could turn out to be profitable
Archer-Daniels-Midland is engaged in trading agricultural commodities and processing them. With its strong capital allocation policy and significant e...
Epr properties: a strong play despite uncertainty
The stock has been under pressure ever since COVID-19. EPR Properties has high exposure to the theater business, accounting for over 40% of its annual...
Ascendis pharma: recent fda setbacks present a buying opportunity
We are upgrading from a hold to buy rating for ASND following a 35% drop in stock price after FDA deficiency findings in the NDA for TransCon PTH for ...
Div: out of favor amid the tech-led rally
The high-dividend factor has lagged so far in 2023. With growth stocks soaring in recent months, low-quality high-yielders have sagged....
3 reasons tjx stock shines in turbulent times
Among the things investors should like about TJX Companies (NYSE: TJX ) is its popularity among working-class and middle-class consumers who are look...
Soundhound ai: progressing rapidly
SoundHound AI: Progressing Rapidly...
Xpeng unveils new ev platform designed to cut production costs
Chinese electric vehicle maker XPeng unveiled Sunday its new platform architecture for making vehicles that will set the foundation for future product...
Dave & buster's entertainment: a value stock that mixes food with fun
Dave & Buster's is a complicated firm because of a large financial transaction the company completed last year. The picture is further complicated by ...
Merck offers to buy prometheus for $10.8 billion
Merck & Co. Inc. has agreed to buy Prometheus Biosciences Inc. for about $10.8 billion. Su Keenan reports on Bloomberg Television....
Report: 'panicked' google rebuilding search engine in ai race
Google is reportedly building an all-new search engine amid increased competition from AI-driven rivals....
Sea: it's finally time to put sea on the watch list
After falling more than 80% from its 2021 heights, Sea has rebounded >50% year to date. The e-commerce business has seen a massive turnaround in profi...
Apple tops 1 million developers in india, ‘excited to build on our long-standing history', says tim cook
Apple now supports more than 1 million developer jobs in India, the company said as it gears up major expansion in the South Asian market. The iPhone-...
Vinfast ships 2nd batch of longer-range electric suvs to north america
Vietnam's electric vehicle maker VinFast said on Monday it had shipped a second batch of 1,879 longer-range VF 8 sport utility vehicles (SUVs), as it ...
Microvast needs a wave of renewable energy euphoria and hope
Microvast's common shares remain under pressure even after its entry into the utility-scale battery storage market. The company might see the $200 mil...
Netflix down for more than 11,000 us users -downdetector
Netflix Inc. is down for more than 11,000 users in the United States on late Sunday, according outage tracking website Downdetector.com....
Dominion defamation lawsuit against fox news delayed
Dominion Voting Systems' $1.6 billion defamation lawsuit against Fox News has been delayed on the eve of its scheduled start date, an official for the...
Genco: profit from the dry bulk shipping recovery with a margin of safety
Genco has a generous and sustainable dividend policy that rewards shareholders with an annualized yield of 17% on the current stock price. GNK has a s...
Apple: losing visibility
Apple continues to delay and push out the launch of AR/VR devices. The tech giant might never launch the AR Glasses after the product release is pushe...
G-7 talks may shed light on allies' reaction to u.s. intel leak
HANOI — While the Biden administration sees minimal damage from the disclosure of highly classified documents related to the war in Ukraine and U.S....
Physical gold etf (aaau) hits new 52-week high
For investors seeking momentum, Goldman Sachs Physical Gold ETF AAAU is probably on radar. The fund just hit a 52-week high and is up 26.53 % from its...
Gm gambles on in-house tech over apple and google apps
Last month, General Motors tapped Google to help create electric vehicle infotainment systems. Google, but not the company's Android Auto, or Apple's ...
Instagram debuts gift offerings for creators
Meta is expanding its Instagram gift program to draw more creators to the platform. The social media company launched the gift feature last year to gi...
Daimler truck recalls 54,375 trucks for possible windshield wiper defect
A year ago, Daimler Truck North America (DTNA) recalled 689 Western Star trucks for faulty windshield wipers. That issue now has swelled to a recall o...
3 stocks to buy before the fed starts to cut interest rates
Most analysts agree that the Federal Reserve will likely start to cut rates later this year, and buying stocks of companies that benefit from such a r...
Moderna, merck combo cancer-vaccine treatment shows ‘significant' promise
A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 4...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Amazon: investors must know this heading into earnings
Amazon: Investors Must Know This Heading Into Earnings...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...